Gland Pharma Limited (GLAND.NS) NSE
Currency In INR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 279.46B |
| Enterprise Value | 248.7B |
| P/E Ratio | 41.15 |
| PEG Ratio | 0.88 |
| Price/Sales Ratio | 6.92 |
| Price/Book Ratio | 4.49 |
| Enterprise/Revenue | 6.92 |
| Enterprise/EBITDA | 23.42 |
Fiscal Year
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.17 |
| Operating Margin | 0.2 |
AD
Management Effectiveness
| Return On Assets | 0 |
| Return On Equity | 0.11 |
Income Statement
| Revenue | 64.31B |
| Revenue/Share | 408.03 |
| Gross Profit | 19.32B |
| EBITDA | 19.22B |
| Net Income | 10.27B |
| Diluted EPS | 62.28 |
Balance Sheet
| Total Cash | 33.59B |
| Total Cash/Share | 0 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 0 |
| Book Value Per Share | 628.42 |
Price History
| 52-Week Change | 44.03 |
| 52-Week High | 3,039.8 |
| 52-Week Low | 1,573.6 |
| Moving Average 50 Days | 2,513.36 |
| Moving Average 200 Days | 1,993.67 |
Statistics
| Average Volume | 731,612 |
| Shares Outstanding | 164.96M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 20 |
| Trailing Annual Dividend Yield | 0.71 |
| Payout Ratio | 0.26 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
